Previous 10 | Next 10 |
No matter what industry we are talking about, political decisions, and policy changes can affect the price of the stocks in that industry, and Integra Lifesciences Hldg (NASDAQ: IART) is not an exception. IART like every other company, it will experience ebbs and flows based on th...
PRINCETON, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Shaundra Clay to its board of directors, effective today. “We are delighted to welcom...
Whether a stock moves fast or slow, one thing is always true. The forces of supply and demand determine the price of Integra Lifesciences Hldg (NASDAQ: IART) and every other stock on the market. The price someone is willing to pay for IART directly impacts its price, but tha...
This is not EF Hutton, but it could be more powerful. A picture speaks a thousand words, they say, and the price action of Integra Lifesciences Hldg (NASDAQ: IART) tells an important story. The movement tells us where investors perceive value, or the lack of it, and if we pa...
AxoGen has reported two consecutive quarters of double-digit growth despite lower trauma presentations during the pandemic and restrictions on marketing/training efforts. Clinical data continue to support the company's key products, with patients experience reduced pain/improved sensa...
Trading Integra Lifesciences Hldg (NASDAQ: IART) or any other stock for that matter requires a degree of disciple that not every investor has. Even those that have discipline often fail to adhere to those disciplines sometimes, and this can cause problems, but hopefully the guides...
When we read the charts for Integra Lifesciences Hldg (NASDAQ: IART) we are able to reach conclusion that are not otherwise discernable. We can see where buy signals exist, where sell signals exist, and where risk controls should be implemented. These are what create trading...
Integra LifeSciences has made some interesting bolt-on M&A in recent times and has seen the business stabilize. I mostly like the speed at which operations have turned to normal with a good outlook seen for 2021. After a 50% return in just about half a year the immediate appea...
PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On February 24, 2021, Carrie Anderson, execut...
Integra LifeSciences Holdings Corporation (IART) Q4 2020 Earnings Conference Call February 18, 2021 08:30 ET Company Participants Mike Beaulieu - Director, Investor Relations Peter Arduini - President & Chief Executive Officer Carrie Anderson - Chief Financial Officer Glenn Coleman - Chie...
News, Short Squeeze, Breakout and More Instantly...
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
2024-07-30 13:15:02 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for IART on July 30, 2024 11:36AM ET. The previous analyst recommendation was Market Outperform. IART was trading at $24.945 at issue of the analyst recommendation. The overall analyst ...
2024-07-30 10:00:08 ET Richard Newitter from Truist Financial issued a price target of $26.00 for IART on 2024-07-30 08:59:00. The adjusted price target was set to $26.00. At the time of the announcement, IART was trading at $24.59. The overall price target consensus is ...
2024-07-30 06:30:09 ET Citigroup analyst issues SELL recommendation for IART on July 30, 2024 03:24AM ET. The previous analyst recommendation was Neutral. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : SELL. Current...